The purpose of this document is to provide interim guidance on laboratory biosafety related to the testing of clinical specimens of patients that meet the case definition of coronavirus disease (COVID-19)

Probenmaterial für die PCR-Diagnostik zum direkten Erregernachweis Verpackung und Versand Empfehlungen zum Umgang mit Probenmaterial Direkter Erregernachweis durch RT-PCR Antikörpernachweise (indirekter Nachweis einer Infektion) Antigennachweise Bemerkungen zur Interpretation von Laborergebnissen Ansprechpartner zu Fragen der Labordiagnostik und Referenzuntersuchungen: Konsiliarlabor für Coronaviren Gesellschaft für Virologie Vorgehen bei Patienten mit bestätigter SARS-CoV-2-Infektion Stand: 18.5.202

Lista de preguntas y respuestas sobre la priorización de pruebas diagnósticas para la confirmación de la infección por el SARS-CoV-2 orientada a dirigir las necesidades de adquisición de los sistemas de salud

This document provides brief information answering common questions regarding COVID-19 diagnostic tests and how to prioritize them to the patients most in need.

The following catalogue lists all the medical devices including personal protective equipment, medical equipment, medical consumables, single use devices and laboratory and test related devices.

This list present the different types of medical devices including medical equipment, personal protective equipment (PPE), and other medical supplies for the management of COVID-19 patients. The list describe alternative options that should be considered based on available infrastructure, health workforce and technologies. These devices are listed in no priority order. Please note some are capital equipment that requires accessories, spare part and extended warranties, for more information please consult the technical specifications listed below and the manufacturer’s recommendation

This tool has been designed to assess the capacity of laboratories that have implemented or intend to implement testing for SARS-CoV-2, the virus that causes novel coronavirus disease 2019 (COVID-19). The tool is a shortened version of the 2012 Laboratory assessment tool that is widely used to assess national laboratory systems and the capacity of laboratory Assessors can use the tool, and customized if needed, to meet local requirements or assessment context. This tool is an Excel file, which enables automatic calculations of module indicators. https://apps.who.int/iris/bitstream/handle/10665/331715/WHO-2019-nCoV-Lab_Assessment_Tool_Data-2020.1-eng.xls

Countries who have no testing capacity and national COVID-19 laboratories with limited experience on COVID-19 virus testing are encouraged to send the first five positives and the first ten negative COVID-19 samples to WHO reference laboratories providing confirmatory testing for COVID-19. Updates 29 April 202

Many in-house and commercial assays that detect the COVID-19 virus have been developed or are currently under development. Many of these molecular assays are currently being validated in partner laboratories. An overview of assays that have applied to FIND for participation in their assay assessment work can be found her

Este documento apresenta uma orientação provisória aos laboratórios e diferentes atores envolvidos na realização de exames laboratoriais para o vírus COVID-19. Ele baseia-se parcialmente na orientação provisória para os exames laboratoriais do coronavírus da Síndrome Respiratória do Oriente Médio (MERS).1-6 As informações sobre a infecção em humanos pelo vírus COVID-19 estão evoluindo e a OMS continua a monitorar os acontecimentos e revisar as recomendações conforme necessário. Este documento será revisado conforme novas informações forem disponibilizadas